Nicotinic α5 receptor subunit mRNA expression is associated with distant 5' upstream polymorphisms.
Nicotinic α5 receptor subunit mRNA expression is associated with distant 5' upstream polymorphisms.
复制标题
DOI:
10.1038/ejhg.2010.120
复制
发表时间:
2011-01
期刊:
影响因子:
--
通讯作者:
中科院分区:
文献类型:
--
作者:
CHRNA5, encoding the nicotinic α5 subunit, is implicated in multiple disorders, including nicotine addiction and lung cancer. Previous studies demonstrate significant associations between promoter polymorphisms and CHRNA5 mRNA expression, but the responsible sequence variants remain uncertain. To search for cis-regulatory variants, we measured allele-specific mRNA expression of CHRNA5 in human prefrontal cortex autopsy tissues and scanned the CHRNA5 locus for regulatory variants. A cluster of six frequent single nucleotide polymorphisms (rs1979905, rs1979906, rs1979907, rs880395, rs905740, and rs7164030), in complete linkage disequilibrium, fully account for a >2.5-fold allelic expression difference and a fourfold increase in overall CHRNA5 mRNA expression. This proposed enhancer region resides more than 13 kilobases upstream of the CHRNA5 transcription start site. The same upstream variants failed to affect CHRNA5 mRNA expression in peripheral blood lymphocytes, indicating tissue-specific gene regulation. Other promoter polymorphisms were also correlated with overall CHRNA5 mRNA expression in the brain, but were inconsistent with allelic mRNA expression ratios, a robust and proximate measure of cis-regulatory variants. The enhancer region and the nonsynonymous polymorphism rs16969968 generate three main haplotypes that alter the risk of developing nicotine dependence. Ethnic differences in linkage disequilibrium across the CHRNA5 locus require consideration of the upstream enhancer variants when testing clinical associations.
登录
查看更多内容
DOI:
10.1002/ajmg.b.30828
发表时间:
2009-06-05
期刊:
American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics
影响因子:
--
作者:
Saccone NL;Saccone SF;Hinrichs AL;Stitzel JA;Duan W;Pergadia ML;Agrawal A;Breslau N;Grucza RA;Hatsukami D;Johnson EO;Madden PA;Swan GE;Wang JC;Goate AM;Rice JP;Bierut LJ
通讯作者:
Bierut LJ
影响因子:
11.2
作者:
Liu P;Yang P;Wu X;Vikis HG;Lu Y;Wang Y;Schwartz AG;Pinney SM;de Andrade M;Gazdar A;Gaba C;Mandal D;Lee J;Kupert E;Seminara D;Minna J;Bailey-Wilson JE;Spitz M;Amos CI;Anderson MW;You M
通讯作者:
You M
DOI:
10.1161/hypertensionaha.109.133033
发表时间:
2009-07
期刊:
Hypertension (Dallas, Tex. : 1979)
影响因子:
--
作者:
Kumar P;Pandey KN
通讯作者:
Pandey KN
影响因子:
5.8
作者:
Johnson, Andrew D.;Handsaker, Robert E.;de Bakker, Paul I. W.
通讯作者:
de Bakker, Paul I. W.
影响因子:
11.2
作者:
Saccone NL;Wang JC;Breslau N;Johnson EO;Hatsukami D;Saccone SF;Grucza RA;Sun L;Duan W;Budde J;Culverhouse RC;Fox L;Hinrichs AL;Steinbach JH;Wu M;Rice JP;Goate AM;Bierut LJ
通讯作者:
Bierut LJ